Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-091757 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
7,378
Total Value
$486,069.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 4,392 | $65.52 | $287,771.75 | 88,197 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 2,986 | $66.41 | $198,297.27 | 85,211 | Direct | โ | View Details |